By n.leuba, 13 September, 2021 CTWG/GTWG - International Regulatory Frameworks for Cell and Gene Therapies - now published The IPRP Cell Therapy Working Group (CTWG) and Gene Therapy Working Group (GTWG) have developed the International Regulatory Frameworks for Cell and G
By n.leuba, 23 June, 2021 QWG - Publication of Quality Assessment Report (QAR) – Full Dossier template The IPRP Quality Working Group (QWG) has developed the IPRP Quality Assessment Report (QAR) – Full Dossier template for the assessment of technical in
By n.leuba, 22 June, 2021 IPRP - 7th Meeting - Public Statement The Management Committee (MC) of the International Pharmaceutical Regulators Programme (IPRP) held its seventh meeting on the 7th and 8th of June 2021
By n.leuba, 21 January, 2021 BWG Training Manual The Working Group on Biosimilars (BWG) has published a Training Manual for Regulatory Reviewers on The Basics of the Clinical Comparability Exercise f
By a.latrive, 3 December, 2020 IPRP - 6th Meeting - Public Statement The Management Committee (MC) of the International Pharmaceutical Regulators Programme (IPRP) held its sixth meeting on the 19th and 20th of November
By c.angulo, 7 August, 2020 Survey on Liposomes from Nanomedicines WG The NWG is conducting a Survey on Regulatory Requirements and Research Needs for Liposome Products amongst stakeholders, including Regulatory Agencies
By c.angulo, 22 July, 2020 Updated IDMP FAQ The Working Group on Identification of Medicinal Products (IDMP) has updated its Frequently Asked Questions (FAQ) document to address questions relate
By c.angulo, 11 June, 2020 IPRP - 5th Meeting - Public Statement The Management Committee (MC) of the International Pharmaceutical Regulators Programme (IPRP) held its fifth meeting on the 28th of May 2020. Represen